Kenneth Greenberg, PhD, SonoThera co-founder and CEO, dives into the translatability of SonoThera's ultrasound-mediated nonviral platform that’s shown paradigm-shifting potential. The post Have Microbubbles Burst Through the Barriers of Genetic Medicine Delivery? appeared first on Inside Precision Medicine .